Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): description and data in its first year of operation

Tejera Vaquerizo, Antonio; Segura Tigell, Sonia; REGESMEL group

doi:http://dx.doi.org/10.1016/j.ad.2024.05.013

Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): description and data in its first year of operation

License

Citation

Tejera-Vaquerizo A, Boada A, Puig S, Nagore E, Fernández-de-Misa R, Ferrándiz L, et al. Melanoma registry of the spanish academy of dermatology and venereology (REGESMEL): description and data in its first year of operation. Actas Dermosifiliogr. 2024 Jul-Aug;115(7):T663-T669. DOI: 10.1016/j.ad.2024.05.013

Abstract

Introduction: The incidence of melanoma is rising in Spain. The prognostic stages of patients with melanoma are determined by various biological factors, such as tumor thickness, ulceration, or the presence of regional or distant metastases. The Spanish Academy of Dermatology and Venereology (AEDV) has encouraged the creation of a Spanish Melanoma Registry (REGESMEL) to evaluate other individual and health system-related factors that may impact the prognosis of patients with melanoma. The aim of this article is to introduce REGESMEL and provide basic descriptive data for its first year of operation. Methods: REGESMEL is a prospective, multicentre cohort of consecutive patients with invasive cutaneous melanoma that collects demographic and staging data as well as individual and healthcare-related baseline data. It also records the medical and surgical treatment received by patients. Results: A total of 450 cases of invasive cutaneous melanoma from 19 participant centres were included, with a predominance of thin melanomas≤1mm thick (54.7%), mainly located on the posterior trunk (35.2%). Selective sentinel lymph node biopsy was performed in 40.7% of cases. Most cases of melanoma were suspected by the patient (30.4%), or his/her dermatologist (29.6%). Patients received care mainly in public health centers (85.2%), with tele-dermatology resources being used in 21.6% of the cases. Conclusions: The distribution of the pathological and demographic variables of melanoma cases is consistent with data from former studies. REGESMEL has already recruited patients from 15 Spanish provinces and given its potential representativeness, it renders the Registry as an important tool to address a wide range of research questions.